Literature DB >> 14678608

Primary infection of a male plasma donor with divergent HIV variants from the same source followed by rapid fluctuations in their relative frequency and viral recombination.

Flavien Bernardin1, Belinda L Herring, Lorraine Peddada, Eric L Delwart.   

Abstract

The replication of two HIV-1 variants (>4.0% divergent in the env gene) was observed during primary infection of a frequent plasma donor. Phylogenetic analysis indicated that both HIV-1 variants likely originated from the same source. Heteroduplex tracking analysis of the env V3-V5 region indicated that one of these variant emerged in the plasma at the time of seroconversion, 15 days after the initial detection of HIV-1 RNA. Sequencing of the entire protein-coding region of plasma viruses from Days 2, 22, and 31 showed possible regions of recombination in the pol locus occurring within the first month of infection. The very rapid fluctuations of HIV-1 variant frequencies and their recombination during primary infection may reflect changes in their relative fitness in the face of developing immunological responses.

Entities:  

Mesh:

Year:  2003        PMID: 14678608     DOI: 10.1089/088922203322588369

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes.

Authors:  Flavien Bernardin; Denice Kong; Lorraine Peddada; Lee Ann Baxter-Lowe; Eric Delwart
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.

Authors:  Manish Sagar; Erin Kirkegaard; E Michelle Long; Connie Celum; Susan Buchbinder; Eric S Daar; Julie Overbaugh
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

4.  Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.

Authors:  Loury Janbazian; David A Price; Glenda Canderan; Abdelali Filali-Mouhim; Tedi E Asher; David R Ambrozak; Phillip Scheinberg; Mohamad Rachid Boulassel; Jean-Pierre Routy; Richard A Koup; Daniel C Douek; Rafick-Pierre Sekaly; Lydie Trautmann
Journal:  J Immunol       Date:  2011-12-30       Impact factor: 5.422

5.  Significantly longer envelope V2 loops are characteristic of heterosexually transmitted subtype B HIV-1 in Trinidad.

Authors:  Aneisha M Collins-Fairclough; Manhattan Charurat; Yuka Nadai; Maria Pando; Maria M Avila; William A Blattner; Jean K Carr
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

6.  Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides.

Authors:  Mehrnoosh Doroudchi; Oleg Yegorov; Tom Baumgartner; Anne-Elen Kernaleguen; Gaelle Breton; Michel L Ndongala; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Nicole F Bernard; Rafick-Pierre Sékaly; Bader Yassine-Diab
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

7.  Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus.

Authors:  Melissa J Churchill; Lisa Chiavaroli; Steven L Wesselingh; Paul R Gorry
Journal:  Retrovirology       Date:  2007-07-01       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.